• Iyabo Adebisi Department of Pharmacology and Toxicology, Usmanu Dan-Fodiyo University, Sokoto-Nigeria
  • Tijjani Rabiu Giaze Department of Pharmacology and Toxicology, Usmanu Dan-Fodiyo University, Sokoto-Nigeria




Pregnancy, Teratogenicity, Pre-eclampsia, Drug utilization, Sokoto specialist


Objective: Drugs prescribed in pregnancy may diffuse across the placenta to the fetus thereby posing a great risk of teratogenicity. In this study, drug utilization pattern in pregnancy amongst inpatient and outpatient groups was studied retrospectively in a specialist hospital in the North Western region of Nigerian.

Methods: Drug prescription information was collected from case notes of 2634 patients that attended the antenatal clinic on an outpatient basis and those that were admitted due to complication(s) for a period of six months. Data collected were analyzed using Microsoft excel software and compared with FDA pregnancy categorization of drugs.

Results: In the outpatient group, 215 patients had complaints that warranted the use of prescription drugs while in the inpatient group, 69 patients had complications that necessitated hospitalisation. In the outpatient group, prescribed drugs for the treatment of malaria (34%) and urinary tract infection (25%) were predominantly from FDA category B. In the inpatient group, drugs for malaria (18%), anemia (11.6%) and pre-eclampsia (11.6%) were the most prescribed. In the management of anemia, drugs prescribed were purely from FDA category A, while, in the case of pre-eclampsia, a significant amount of prescribed drugs were from FDA categories C and N.

Conclusion: In both patient groups, no drug from FDA category X was prescribed. Therefore, it can be concluded that drugs prescribed in pregnancy in specialist hospital, Sokoto-Nigeria, were within a reasonable limit of safety. However, the use of drugs such as diazepam whose risks are yet to be classified should be avoided.


Download data is not yet available.


Sachadeva P, Ptael BG, Patel BK. Drug use in pregnancy; a point to ponder. Indian J Pharm Sci 2009;71:1-7.

Briggs GG, Greeman RK, Yaffe SJ. Drugs in pregnancy and lactation: a reference guide to foetal and neonatal risk. 6th Edition. Philadelphia: Lippincott Williams and Wilkins Publishers; 2002. p. 16-8.

British National Formulary. Pregnancy 2006;52:760.

Sharma R, Kapoor B, Verma U. Drug utilisation pattern during pregnancy in North India. Indian J Med Sci 2006;60:277–87.

Koren G, Pastuszak A, Ito S. Drugs in pregnancy. N Eng J Med 1998;338:1135–7.

FDA pregnancy categories, compiled by CARE Northwest. Available from: http://depts.washington.edu/druginfo/ Formulary/Pregnancy.pdf. [Last accessed on 20 Mar 2016]

World Health Organization Collaborative group on drug use in pregnancy. Medication during pregnancy: an intercontinental cooperative study. Int J Gynand Obs 1992;39:185–96.

Tsega B, Shemsu A, Ergetie Z. Assessment of drug utilisation among pregnant women in the university of gondar teaching hospital, Northwest Ethiopia. Glob J Pharm Res 2013;2:1434-40.

Abubakar K, Abdulkadir R, Abubakar SB, Jimoh AO, Ugwah-Oguejiofor JC, Danzaki A. Drug utilisation pattern in pregnancy in tertiary Hospital in Sokoto, North West Nigeria. J Health Sci 2014;4:99-104.

Ilyaz Md, Roya Rozati, Hafeez F, Tahniyath F, Hasbeen S, Asgfaq Hussein Md. Drug utilisation pattern in pregnancy: a scope for Improvement in the current prescription practices. Int J Pharm 2014;4:156-67.

Brown H, Small M. The role of the maternal-fetal medicine in review and prevention of maternal deaths. Perinatology 2012;36:27–30.

CDC Fact File on the list of places in the world where malaria transmission occurs. Available from: http://www.cdc.gov/ malaria/travelers/country_table/a.html. [Last accessed on 20 Mar 2016]



How to Cite

Adebisi, I., and T. R. Giaze. “DRUG UTILIZATION PATTERN IN PREGNANCY AMONGST INPATIENT AND OUTPATIENT GROUPS IN A SPECIALIST HOSPITAL, NORTH-WESTERN NIGERIA”. International Journal of Pharmacy and Pharmaceutical Sciences, vol. 9, no. 3, Mar. 2017, pp. 84-87, doi:10.22159/ijpps.2017v9i3.12486.



Original Article(s)